SutroVax

SutroVax

SutroVax

SutroVax is dedicated to delivering best-in-class conjugate vaccines & complex antigen-based vaccines to prevent deadly infectious diseases.
Type
B2b
Founded
2013
Raised
$277M
Follow us
Alexa global traffic share
Latest funding Show all
$85,000,000
Venture capital (Series C) - 2018
Foresite Capital TPG Growth Abingworth +6
Team Size
2
Employees
$110,000,000 Venture capital (Series D)
FinSMEs

SutroVax Raises $110M in Series D Financing

$85,000,000 Venture capital (Series C)
PE HUB , FinSMEs

SutroVax reels in $85 mln Series C

Messaging
Xconomy

SutroVax Lands $64M From Roche, Others to Back Vaccine Studies

Health Funding
$22,000,000 Venture capital (Series A)
Xconomy

With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines

Health